The Allergic Rhinitis drugs in development market research report provides comprehensive information on the therapeutics under development for Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Allergic Rhinitis. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued products.
GlobalData tracks 83 drugs in development for Allergic Rhinitis by 71 companies/universities/institutes. The top development phase for Allergic Rhinitis is phase ii with 28 drugs in that stage. The Allergic Rhinitis pipeline has 73 drugs in development by companies and ten by universities/ institutes. Some of the companies in the Allergic Rhinitis pipeline products market are: Inmunotek, Regeneron Pharmaceuticals and ALK-Abello.
The key targets in the Allergic Rhinitis pipeline products market include Histamine H1 Receptor (HRH1), Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1), and Immunoglobulin E (IgE) .
The key mechanisms of action in the Allergic Rhinitis pipeline product include Histamine H1 Receptor (HRH1) Antagonist with ten drugs in Phase III. The Allergic Rhinitis pipeline products include 12 routes of administration with the top ROA being Nasal and ten key molecule types in the Allergic Rhinitis pipeline products market including Small Molecule, and Allergenics (Allergen).
Allergic Rhinitis overview
Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy or runny nose, sneezing, swollen eyelids, and itchy mouth, throat, or ears.
For a complete picture of Allergic Rhinitis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
